Evaluation of Lancets for Pain Perception and Capillary Blood Volume for Glucose Monitoring

David Warunek; Ana K Stankovic

doi:10.29074/ascls.21.4.215

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

David Warunek, PhD MBA MT(ASCP)⇑
1. is the worldwide director, Scientific Affairs, BD Diagnostics – Preanalytical Systems, Franklin Lakes NJ
Ana K Stankovic, PhD MD MSPH
1. is the vice president, Medical, Scientific Affairs and Clinical Operations, BD Diagnostics – Preanalytical Systems, Franklin Lakes NJ

Address for correspondence: David Warunek PhD MBA MT (ASCP), worldwide director, Scientific Affairs, BD Diagnostics – Preanalytical Systems, 1 Becton Drive, Franklin Lakes NJ 07417. (201) 847-4376. David_Warunek{at}bd.com.

Abstract

OBJECTIVE: The purpose of this study was to assess patient pain perception and capillary blood volume of four currently marketed lancets [BD Microtainer Contact-Activated Lancet, Low Flow (Contact-Activated Lancet); LifeScan OneTouch SureSoft Gentle (OneTouch SureSoft Gentle); BD Genie Blue; SurgiLance Safety] in a diabetic population following routine finger-puncture procedures and glucose monitoring.

METHODS: Data were collected from adult subjects diagnosed with type I or type II diabetes mellitus at a 300-bed US hospital following finger-puncture procedures for glucose monitoring. Based on quantitative and qualitative measurements, each blood collection device was evaluated for pain perception and calculated total capillary blood volume.

RESULTS: A total of 80 subjects received four skin punctures in an alternating finger and hand sequence using each lancet. The ten clinicians (nurses and phlebotomists) conducted the study, collected and then calculated total capillary blood volume. It was determined that the Contact-Activated Lancet produced less perceived pain and bleeding, while obtaining an adequate capillary blood volume for glucose monitoring.

CONCLUSION: This study demonstrated that the Contact-Activated Lancet provided an adequate sample volume required for blood glucose monitoring. In addition, less perceived pain was elicited with this lancet when compared with the other lancets evaluated in the study.